Allogene Therapeutics, Inc. (ALLO) vs BlossomHill Therapeutics, Inc. (BLSM)
A side-by-side comparison of Allogene Therapeutics, Inc. and BlossomHill Therapeutics, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
ALLO
Allogene Therapeutics, Inc.
$1.46HealthcareDelayed quote: Oct 6, 2026, 3:20 PM EDT
BLSM
BlossomHill Therapeutics, Inc.
$17.76HealthcareDelayed quote: Oct 6, 2026, 3:20 PM EDT
Total return — ALLO vs BLSM
growth of $100 · dividends reinvested · last 1yALLO -23.1% (-23.1%/yr)BLSM +24.6% (+24.6%/yr)BLSM compounded faster over this window
ALLO BLSM
ALLO vs BLSM: by the numbers
- •BLSM is the larger company ($516M vs $504M market cap).
- •Both run net losses; BLSM's is the smaller (0.00% vs -3566.68% net margin).
Metrics side by side
Valuation
| Metric | ALLO | BLSM |
|---|---|---|
| P/S ratio | 108.60 | N/A |
| P/B ratio | 1.16 | N/A |
Profitability
| Metric | ALLO | BLSM |
|---|---|---|
| Gross margin | 0.00% | 0.00% |
| Operating margin | 0.00% | 0.00% |
| Net margin | -3566.68% | 0.00% |
| ROE | -37.94% | N/A |
| ROIC | -34.79% | -43.41% |
Growth (annualized)
| Metric | ALLO | BLSM |
|---|---|---|
| Revenue CAGR (5Y) | -34.47% | N/A |
| Total return CAGR (5Y) | -42.72% | N/A |
Go deeper
Dig into the metrics
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.